Abel Torres-Espin is assistant professor at the School of Public Health Sciences at the University of Waterloo in Canada; adjunct professor at the University of Alberta and assistant adjunct professor at the Brain and Spinal Injury Center in the Weill Institute of Neurosciences at University of California, San Francisco.
Abel Torres-Espin
Assistant adjunct professor
Brain and Spinal Injury Center (BASIC) University of California, San Francisco
From this contributor
By
Adam Ferguson, Hannah Radabaugh, Abel Torres-Espin
4 March 2024
7 min read
Pooling data points to new potential treatment for spinal cord injury
By gathering raw data from multiple labs, we identified an overlooked predictor of recovery after spinal cord injury. Many more insights remain trapped in scattered data.
Explore more from The Transmitter
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
Sylvia Fogel, reshaping U.S. autism research strategy
In a wide-ranging and provocative interview, the chair of the federal Interagency Autism Coordinating Committee shares her views on vaccines, regression, neuroimmune conditions and more.
By
Brady Huggett
17 September 2026 | 1 min read
Human brain organoids flourish in emptied mouse cortex
The chimeric mice could help untangle the biology of human brain development or conditions such as autism.
Human brain organoids flourish in emptied mouse cortex
The chimeric mice could help untangle the biology of human brain development or conditions such as autism.
By
Brianna Abbott
16 September 2026 | 6 min read
What if Hegel were a neuroscientist?
Andrea Gambarotto shares what Hegel and enactivism have in common: an agency-first approach to understanding minds and brains.
What if Hegel were a neuroscientist?
Andrea Gambarotto shares what Hegel and enactivism have in common: an agency-first approach to understanding minds and brains.
By
Paul Middlebrooks
16 September 2026 | 1 min read